Genetic Analysis AS: CFO resigns to pursue other opportunities

OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt has decided to resign as CFO to take on a new position in another company and industry. He will remain in his current role until the end of August 2024, ensuring a smooth and efficient transition for GA. Aamodt has been with GA since February 2021, and GA has initiated a process to recruit his replacement.

Ronny Hermansen, CEO of Genetic Analysis, comments:

“I would like to thank Eilert for his valuable contribution to GA over the years, where he has established a finance function that complies with all requirements of being a listed company. We wish him all success in his new job.”

Please read the full press release: